Evang. Kliniken Essen-Mitte
Essen, North Rhine-Westphalia 45136
1 studies enrolling now · 2 studies all time
What they study most
Breast Cancer, Resectable Non-small Cell Lung Cancer
Studies at this site
- A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence — Recruiting now
- A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery — Running, not enrolling